Skip to main navigation menu Skip to main content Skip to site footer

PETRO study: assessment of thromboprophylaxis and embolic risk in hospitalized patients at a third-level institution in Bogota, Colombia

Estudio PETRO: evaluación de tromboprofilaxis y riesgo embólico en pacientes hospitalizados en una institución de tercer nivel en Bogotá, Colombia




Section
Research article

How to Cite
PETRO study: assessment of thromboprophylaxis and embolic risk in hospitalized patients at a third-level institution in Bogota, Colombia.
rev. colomb. neumol. [Internet]. 2017 Aug. 1 [cited 2024 Dec. 21];29(1):7-18. Disponible en: https://doi.org/10.30789/rcneumologia.v29.n1.2017.233

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Oscar Alberto Sáenz Morales
    Erika Vergara Vela
      Francisco González Acosta
        Paola Bonilla González
          Jorge Andrés Russi Lozano

            Oscar Alberto Sáenz Morales,

            Médico Internista, Neumólogo, Grupo Investigación Urgencias Hospital Santa Clara (HSC), Coordinador Servicio de Urgencias HSC. Bogotá, Colombia.

            Erika Vergara Vela,

            Médica Internista, Epidemióloga, Hospital Santa Clara (HSC). Docente Universidad El Bosque. Grupo Investigación Urgencias Hospital Santa Clara (HSC). Bogotá, Colombia.

            Francisco González Acosta,

            Médico Farmacólogo, Bioeticista, Hospital Santa Clara. Docente titular Universidad El Bosque. Grupo Investigació. Urgencias Hospital Santa Clara (HSC). Bogotá, Colombia.

            Paola Bonilla González,

            Médica Internista, Hospital Santa Clara. Docente Universidad El Bosque, Grupo Investigación Urgencias Hospital Santa Clara (HSC). Bogotá, Colombia.

            Jorge Andrés Russi Lozano,

            Médico Internista, Epidemiólogo, Hospital Santa Clara. Docente Universidad
            El Bosque. Grupo Investigación Urgencias Hospital Santa Clara (HSC). Bogotá,Colombia.

            Angélica Rojas Durán,

            Médica Internista, Hospital Santa Clara. Docente Universidad El Bosque. Grupo Investigación Urgencias Hospital Santa Clara (HSC). Bogotá, Colombia

            Martín Zapata Laguado,

            Residente segundo año Medicina Interna, Universidad el Bosque, Hospital Santa Clara. Bogotá, Colombia.

            Camilo Uhía González,

            Residente tercer año Medicina Interna, Universidad El Bosque, Hospital Santa Clara. Bogotá, Colombia.

            Aware of the fact that venous thromboembolism is the leading cause of death in hospitalized patients, we carried out a study of thromboprophylaxis. The study was of the retrospective type, a case series of medical and surgical patients hospitalized in the emergency ward. We took into account the indications given by the main scales of embolic risk. We used an Excel database and the SPSS 23 software. In most cases, thromboprophylaxis with enoxaparin was used; we found prophylaxis for low risk in 69%, for medium risk in 81%, and for high risk in 92%. The rate of adverse effects was low. This therapy proved to be cost-efficient, safe, and effective. It is necessary to further improve thromboprophylaxis by implementing strategies such as alarms, adherence to guidelines, protocols, and continued education.

            Article visits 1696 | PDF visits 6258


            Downloads

            Download data is not yet available.
            1. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180-90.
            2. Virchow RC. Cellular pathology as based upon physiological and pathological history. [Tr. from the 2nd. ed. of the original by Frank Chance]. Birmingham; Gryphod Editions, Ltd; 1978.
            3. Dickson BC. Venous thrombosis: on the history of Virchow’s Triad. Univ Toronto Med J. 2004;81:166-71.
            4. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 suppl):338S–400S.
            5. Yamada N, Hanzawa K, Ota S, et al. Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis. 2015;8(3):203–9.
            6. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82(4):203-5.
            7. Ashish J. The research priority setting working group of the World alliance for Patient safety. Summary of the evidence on patient safety: implications for research. World Health Organization; 2008.
            8. Abraham Majluf, Espinosa F. Fisiopatología de la trombosis. Medigraphic Anestesia. Gac Med Mexico; 2007.
            9. Lobato-Mendizábal E, Majluf-Cruz A. Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins. Rev Invest Clin. 2000;52:529-45.
            10. Martínez-Murillo C, Quintana-González S, Ambriz-Fernández R, Hernández Paula M. El problema trombótico. Hematología. 2000;1:17-20.
            11. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-94.
            12. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-7.
            13. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51(1-3):70-8.
            14. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Semin Thromb Hemost. 1991;17(Suppl 3):304-12.
            15. Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211-21.
            16. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr,A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344-50.
            17. Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW et al Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212(1):105-12.
            18. Guyatt GH, Akl EA, Gutterman DD, Schunemann HJ. Antithrombotic therapy and prevention of thrombosis, 9th. ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST. 2012;141(2 suppl)7S-47S. doi: 10.1378/chest.1412S3.
            19. Bick RL. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs. 2000;60(3):575-95.
            20. Gould MK, Debitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute vein thrombosis. A metaanalysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-9.
            21. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ.2006;332:325-9.
            Sistema OJS 3.4.0.7 - Metabiblioteca |